Global Psychedelic Drugs Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2024 –2031 |
 Tamaño del mercado (año base) |
USD 2.71 Billion |
 Tamaño del mercado (año de pronóstico) |
USD 7.35 Billion |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
>Mercado mundial de drogas psicodélicas, por fuente (sintética y natural), tipo (empatógenos, disociativos y otros), drogas (ácido gamma-hidroxibutírico, ketamina, psilocibina, dietilamida del ácido lisérgico (LSD), 3,4-metilendioximetanfetamina y otras), aplicación (narcolepsia, depresión resistente al tratamiento, trastorno depresivo mayor, adicción a opiáceos, trastorno de estrés postraumático y otras), vía de administración (oral, inhalación e inyectable), usuario final (hospitales, clínicas especializadas, atención domiciliaria y otras), canal de distribución (farmacias de hospitales, farmacias minoristas y farmacias en línea): tendencias de la industria y pronóstico hasta 2031.
Análisis y tamaño del mercado de drogas psicodélicas
El mercado de las drogas psicodélicas incluye una variedad de sustancias clasificadas como empatógenas, disociativas y otras. Las empatógenas como el MDMA pueden aumentar los sentimientos de empatía y sociabilidad, mientras que las disociativas como la ketamina pueden crear una sensación de desapego de la realidad. Otras drogas psicodélicas, como los hongos psilocibios y el LSD, pueden cambiar la percepción y la cognición.
El tamaño del mercado mundial de drogas psicodélicas se valoró en USD 2.71 mil millones en 2023 y se proyecta que alcance los USD 7.35 mil millones para 2031, con una CAGR del 13,3% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.
Alcance del informe y segmentación del mercado
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2024 a 2031 |
|
Año base |
2023 |
|
Años históricos |
2022 (Personalizable para 2016-2021) |
|
Unidades cuantitativas |
Ingresos en miles de millones de USD, volúmenes en unidades, precios en USD |
|
Segmentos cubiertos |
Origen (sintético y natural), tipo (empatógenos, disociativos y otros), fármacos (ácido gamma-hidroxibutírico, ketamina, psilocibina, dietilamida del ácido lisérgico (LSD), 3,4-metilendioximetanfetamina y otros), aplicación (narcolepsia, depresión resistente al tratamiento, trastorno depresivo mayor, adicción a opiáceos, trastorno de estrés postraumático y otros), vía de administración (oral, inhalación e inyectable), usuario final (hospitales, clínicas especializadas, atención domiciliaria y otros), canal de distribución (farmacias de hospitales, farmacias minoristas y farmacias en línea) |
|
Países cubiertos |
EE. UU., Canadá, México, Alemania, Francia, Reino Unido, Países Bajos, Suiza, Bélgica, Rusia, Italia, España, Turquía, Resto de Europa, China, Japón, India, Corea del Sur, Singapur, Malasia, Australia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico, Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica, Egipto, Israel, Resto de Medio Oriente y África, Brasil, Argentina y Resto de Sudamérica. |
|
Actores del mercado cubiertos |
Jazz Pharmaceuticals, Inc. (EE. UU.), Janssen Pharmaceuticals, Inc. (EE. UU.), Hikma Pharmaceuticals PLC (Reino Unido), Compass (EE. UU.), Verrian (Alemania), Pfizer Inc. (EE. UU.), F. Hoffmann-La Roche Ltd (Suiza), Avadel (Irlanda), Celon Pharma SA (Polonia), Cybin Corp. (Canadá), GH Research (Irlanda), Entheon Biomedical Corp (Canadá), PharmaTher Holdings Ltd. (India), NRx Pharmaceuticals, Inc. (EE. UU.) y Usona Institute (EE. UU.) |
|
Oportunidades de mercado |
|
Definición de mercado
Las drogas psicodélicas son sustancias que pueden provocar cambios en la percepción, el estado de ánimo y la cognición, lo que a menudo da lugar a experiencias subjetivas intensas. Algunos ejemplos de estos compuestos son la psilocibina (presente en ciertos hongos), el LSD y el MDMA. Se dirigen principalmente a los receptores de serotonina del cerebro y se están investigando sus posibles beneficios terapéuticos en el tratamiento de trastornos de salud mental, especialmente cuando se utilizan en entornos supervisados.
Dinámica del mercado de las drogas psicodélicas
Conductores
- Creciente apoyo a la terapia psicodélica
El sector sanitario está aceptando cada vez más la terapia psicodélica, impulsado por numerosos ensayos clínicos que demuestran la promesa terapéutica de sustancias como la psilocibina y el MDMA para trastornos como la depresión, el trastorno de estrés postraumático y la adicción. Esta actitud cambiante entre los profesionales sanitarios y los organismos reguladores está facilitando la incorporación más amplia de la terapia asistida por psicodélicos en los enfoques sanitarios convencionales, lo que impulsa una expansión sustancial del mercado.
- Transición mundial hacia la legalización y despenalización de los psicodélicos
Los gobiernos de todo el mundo están reevaluando sus políticas sobre las drogas psicodélicas, reconociendo su potencial terapéutico en el tratamiento de trastornos de salud mental. Este cambio incluye medidas para despenalizar la posesión e incluso legalizar el uso médico y recreativo. Estos cambios de política están creando nuevas oportunidades para la investigación, el desarrollo y la comercialización en el mercado e impulsando el crecimiento del mercado.
Oportunidades
- Colaboraciones entre la academia y la industria
Las instituciones académicas contribuyen con la investigación y la experiencia científica, mientras que los socios de la industria proporcionan recursos y conocimientos para el desarrollo, la formulación y la comercialización de medicamentos. Esta colaboración acelera los descubrimientos científicos para terapias innovadoras, lo que ofrece oportunidades lucrativas para ambos sectores en medio de una creciente demanda del mercado.
- Aumento de la financiación de la investigación
El aumento de la financiación de la investigación facilita la realización de extensas investigaciones científicas sobre las aplicaciones terapéuticas, los perfiles de seguridad y los mecanismos de acción de los compuestos psicodélicos. Este apoyo financiero fomenta la identificación de nuevos fármacos candidatos y mejora los tratamientos existentes, atrayendo inversiones públicas y privadas e impulsando el crecimiento y la expansión del mercado.
Restricciones/Desafíos
- Obstáculos culturales
En zonas donde predominan los valores conservadores o donde el uso de drogas psicodélicas contradice las normas culturales o las creencias religiosas, la aceptación de estas sustancias puede ser limitada. Esta falta de aceptación podría conducir a una menor demanda de terapias psicodélicas, una menor disposición de los profesionales de la salud a recetarlas y dificultades en los procesos de aprobación regulatoria, lo que puede suponer un desafío para el mercado.
- Mal uso y problemas de seguridad pública
El uso indebido, ya sea recreativo o autoadministrado sin supervisión médica, puede provocar efectos adversos como angustia psicológica o empeoramiento de problemas de salud mental subyacentes. Estos hechos generan dudas entre los reguladores, los profesionales de la salud y el público, lo que altera la aceptación generalizada de las terapias psicodélicas.
Este informe sobre el mercado de drogas psicodélicas proporciona detalles de los nuevos desarrollos recientes, regulaciones comerciales, análisis de importación y exportación, análisis de producción, optimización de la cadena de valor, participación de mercado, impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsillos de ingresos emergentes, cambios en las regulaciones del mercado, análisis estratégico del crecimiento del mercado, tamaño del mercado, crecimientos del mercado por categorías, nichos de aplicación y dominio, aprobaciones de productos, lanzamientos de productos, expansiones geográficas, innovaciones tecnológicas en el mercado. Para obtener más información sobre el mercado de drogas psicodélicas, comuníquese con Data Bridge Market Research para obtener un informe de analista; nuestro equipo lo ayudará a tomar una decisión de mercado informada para lograr el crecimiento del mercado.
Acontecimientos recientes
- En septiembre de 2023, Cybin Inc. anunció una asociación estratégica con Fluence, un reconocido proveedor de educación continua en terapia psicodélica. Esta colaboración tiene como objetivo impulsar la expansión del programa de capacitación EMBARK para el ensayo de fase 3 CYB003
- En octubre de 2022, Numinus Wellness Inc., una empresa líder en el cuidado de la salud mental, lanzó un programa pionero que ofrece ketamina para tratar afecciones médicas crónicas y graves. Inicialmente, este programa innovador se introdujo en las clínicas de Numinus ubicadas en Utah, Columbia Británica y Quebec.
Alcance del mercado de las drogas psicodélicas
El mercado de drogas psicodélicas está segmentado en función de la fuente, el tipo, las drogas, la aplicación, la vía de administración, el usuario final y el canal de distribución. El crecimiento entre estos segmentos le ayudará a analizar los segmentos de crecimiento reducidos en las industrias y brindará a los usuarios una valiosa descripción general del mercado y conocimientos del mercado para ayudarlos a tomar decisiones estratégicas para identificar las principales aplicaciones del mercado.
Fuente
- Sintético
- Natural
Tipo
- Empatógenos
- Disociativos
- Otros
Drogas
- Ácido gamma-hidroxibutírico
- Ketamina
- Psilocibina
- Dietilamida del ácido lisérgico (LSD)
- 3,4-Metilendioximetanfetamina
- Otros
Solicitud
- Narcolepsia
- Depresión resistente al tratamiento
- Trastorno depresivo mayor
- Adicción a los opiáceos
- Trastorno de estrés postraumático
- Otros
Vía de administración
- Oral
- Inhalación
- Inyectable
Usuario final
- Hospital
- Clínicas de especialidades
- Cuidado domiciliario
- Otros
Canal de distribución
- Farmacias Hospitalarias
- Farmacia minorista
- Farmacia en línea
Psychedelic Drugs Market Regional Analysis/Insights
The psychedelic drugs market is analyzed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end-user, and distribution channel as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the market due to the region's high prevalence of mental disorders, and ongoing research and development efforts drive market growth. This sustained leadership highlights North America's crucial role in influencing the direction of the global psychedelic drugs market.
Asia-Pacific is expected to witness significant growth during the forecast period due to expanding healthcare infrastructure and growing public awareness. As the region invests in mental health services and education, along with increasing acceptance of psychedelic therapies, it is emerging as a key contributor to the market's global expansion and development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The psychedelic drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for psychedelic drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the psychedelic drugs market. The data is available for historic period 2016-2021.
Competitive Landscape and Psychedelic Drugs Market Share Analysis
The psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Jazz Pharmaceuticals, Inc. (U.S.),
- Janssen Pharmaceuticals, Inc. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Compass (U.S.)
- Verrian (Germany)
- Pfizer Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Avadel (Ireland)
- Celon Pharma SA.(Poland)
- Cybin Corp. (Canada)
- GH Research (Ireland)
- Entheon Biomedical Corp (Canada)
- PharmaTher Holdings Ltd. (India)
- NRx Pharmaceuticals, Inc. (U.S.)
- Usona Institute (U.S.)Top of Form
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL Psychedelic drugs MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type of Psychedelic drugs LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET APPLICATION COVERAGE GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- epidemiology
- REGULATORY FRAMEWORK: GLOBAL PSYCHEDELIC DRUGS MARKET
- REGULATORY SCENARIO IN INDIA
- REGULATORY SCENARIO IN UAE
- REGULATORY SCENARIO IN AFRICA
- REGULATORY SCENARIO IN THE U.S.
- REGULATORY SCENARIO IN BRAZIL
- REGULATORY SCENARIO IN THE U.K.
- Pipeline analysis
- market overview
- DRIVERS
- GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
- INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
- RISING AWARENESS TOWARDS MENTAL HEALTH
- ONGOING CLINICAL TRIALS
- RISE IN PRODUCT APPROVALS
- RESTRAINTS
- STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
- HIGH COST OF PSYCHEDELIC DRUGS
- PATENT EXPIRY OF PSYCHEDELIC DRUGS
- OPPORTUNITIES
- INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
- BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
- UPCOMING REHABILITATION CENTERS
- AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
- CHALLENGES
- SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
- RISE IN ALTERNATIVES
- OTHER TREATMENT OPTIONS
- COVID-19 IMPACT ON GLOBAL PSYCHEDELIC DRUGS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- global psychedelic drug market, BY source
- overview
- SYNTHETIC
- natural
- global psychedelic drugs MARKET, BY type
- overview
- empathogens
- dissociatives
- others
- global psychedelic drugs MARKET, BY drugs
- overview
- gamma-hydroxybutyric acid
- ketamine
- psilocybin
- others
- global psychedelic drugs MARKET, BY appplication
- overview
- narcolepsy
- Treatment resistant depression
- major depressive disorder
- opiate addiction
- post-traumatic stress disorder
- others
- global psychedelic drug market, BY route of administration
- overview
- oral
- inhalation
- injectable
- global psychedelic drugs MARKET, BY end user
- overview
- hospitals
- Specialty Clinics
- Homecare
- others
- global psychedelic drugs MARKET, BY distribution channel
- overview
- Hospital Pharmacy
- retail Pharmacy
- online Pharmacy
- GLOBAL Psychedelic Drugs MARKET, BY region
- Overview
- NORTH AMERICA
- u.s.
- canada
- mexico
- EUROPE
- Germany
- U.K.
- France
- Italy
- SPAIN
- Russia
- Poland
- Switzerland
- Netherlands
- Hungary
- Austria
- Norway
- Ireland
- Belgium
- Lithuania
- rest of europe
- middle east & africa
- Saudi Arabia
- israel
- EGYPT
- uae
- Global Psychedelic drugs market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Middle East AND Africa
- swot
- company profile
- JAZZ PHARMACEUTICALS, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Pfizer Inc.
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- VERRIAN
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- AVADEL
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- RECENT DEVELOPMENTS
- Celon Pharma S.A.
- COMPANY SNAPSHOT
- PIPELINE PORTFOLIO
- RECENT DEVELOPMENTS
- COMPASS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- HIKMA PHARMACEUTICALS PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- neuroRX, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- PHARMATHER INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- usonainstitute.org
- INSTITUTE SNAPSHOT
- PIPELINE PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Lista de Tablas
TABLE 1 U.S. psychedelic drugs market, company wise pipeline analysis
TABLE 2 U.S. psychedelic drugs market, Research Institute pipeline analysis
TABLE 3 Psychedelics researches, in Europe
TABLE 4 Mental Illness in the U.S. adults, in 2018
TABLE 5 Mental Disorders, in the U.S. adults, in 2018
TABLE 6 More than one in six people in EU countries have a mental health problem
TABLE 7 Men are more likely to die from suicide, in all EU countries
TABLE 8 Mental Disorders causeD by usage of substance disorders, in world, in 2017
TABLE 9 Drug Development Pathway for FDA approval of New Medications
TABLE 10 The 1971 UN Convention on Psychotropic Substances
TABLE 11 cost of psychedelic drugs
TABLE 12 Total costs (direct and indirect) of mental health problems in EU countries, in million and as a share of GDP, In 2015
TABLE 13 psychedelic drugs R&D activities
TABLE 14 Global Psychedelic drug market, By source 2020-2028 (USD Million)
TABLE 15 Global Synthetic in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 16 Global Natural in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 17 global psychedelic drug market, By Type, 2020-2028 (USD Million)
TABLE 18 Global Empathogens in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 19 Global Dissociatives in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 20 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 21 Global Therapy in Psychedelic Drugs Market, By Drugs, 2019-2028 (USD Million)
TABLE 22 Global Gamma-Hydroxybutyric Acid in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 23 Global Ketamine in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 24 Global Psilocybin in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 25 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 26 Global application in psychedelic drugs Market, By Application, 2019-2028 (USD Million)
TABLE 27 Global Narcolepsy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 28 Global Treatment Resistant Depression in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 29 Global Major Depressive Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 30 Global Opiate Addiction in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 31 Global Post-Traumatic Stress Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 32 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 33 Global Psychedelic Drugs Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 34 Global Oral in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 35 Global Inhalation in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 36 Global Injectable in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 37 global psychedelic drug market, By END USER, 2020-2028 (USD Million)
TABLE 38 Global Hospitals in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 39 Global Specialty Clinics in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 40 Global Homecare in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 41 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 42 global medication & supplements in psychedelic drug market, By distribution channel, 2020-2028 (USD million)
TABLE 43 Global Hopitals Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 44 Global Retail Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 45 Global Online Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)
TABLE 46 GLOBAL Psychedelic Drugs MARKET, By Region, 2018-2027 (USD million)
TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 52 NORTH AMERICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 53 NORTH AMERICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 54 NORTH AMERICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 55 u.s.PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 56 u.s. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 57 u.s. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 58 u.s. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 59 u.s. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 60 u.s. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 61 u.s. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 62 canada PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 63 canada PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 64 canada PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 65 canada PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 66 canada PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 67 canada PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 68 canada PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 69 mexico PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 70 mexico PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 71 mexico PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 72 mexico PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 73 mexico PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 74 mexico PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 75 mexico PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 77 EUROPE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 78 EUROPE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 79 EUROPE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 80 EUROPE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 81 EUROPE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 82 EUROPE PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 83 EUROPE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 84 Germany PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 85 Germany PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 86 Germany PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 87 Germany PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 88 Germany PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 89 Germany PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 90 Germany PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 91 U.K. PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 92 U.K. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 93 U.K. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 94 U.K. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 95 U.K. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 96 U.K. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 97 U.K. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 98 France PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 99 France PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 100 France PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 101 France PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 102 France PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 103 France PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 104 France PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 105 Italy PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 106 Italy PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 107 Italy PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 108 Italy PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 109 Italy PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 110 Italy PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 111 Italy PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 112 spain PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 113 Spain PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 114 Spain PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 115 Spain PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 116 Spain PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 117 Spain PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 118 Spain PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 119 RUSSIA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 120 Russia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 121 Russia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 122 Russia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 123 Russia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 124 Russia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 125 Russia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 126 Poland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 127 Poland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 128 Poland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 129 Poland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 130 Poland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 131 Poland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 132 Poland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 133 Switzerland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 134 Switzerland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 135 Switzerland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 136 Switzerland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 137 Switzerland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 138 Switzerland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 139 Switzerland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 140 Netherlands PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 141 Netherlands PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 142 Netherlands PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 143 Netherlands PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 144 Netherlands PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 145 Netherlands PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 146 Netherlands PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 147 Hungary PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 148 Hungary PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 149 Hungary PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 150 Hungary PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 151 Hungary PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 152 Hungary PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 153 Hungary PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 154 Austria PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 155 Austria PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 156 Austria PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 157 Austria PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 158 Austria PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 159 Austria PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 160 Austria PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 161 Norway PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 162 Norway PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 163 Norway PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 164 Norway PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 165 Norway PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 166 Norway PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 167 Norway PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 168 Ireland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 169 Ireland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 170 Ireland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 171 Ireland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 172 Ireland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 173 Ireland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 174 Ireland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 175 Belgium PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 176 Belgium PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 177 Belgium PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 178 Belgium PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 179 Belgium PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 180 Belgium PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 181 Belgium PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 182 Lithuania PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 183 Lithuania PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 184 Lithuania PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 185 Lithuania PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 186 Lithuania PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 187 Lithuania PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 188 Lithuania PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 189 rest of europe PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 193 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 194 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 195 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 196 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 197 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 198 Saudi atrabia PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 199 Saudi Arabia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 200 Saudi Arabia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 201 Saudi Arabia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 202 Saudi Arabia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 203 Saudi Arabia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 204 Saudi Arabia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 205 israel PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 206 israel PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 207 israel PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 208 israel PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 209 israel PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 210 israel PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 211 israel PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 212 egypt PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 213 egypt PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 214 egypt PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 215 egypt PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 216 egypt PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 217 egypt PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 218 egypt PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
TABLE 219 UAE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)
TABLE 220 UAE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)
TABLE 221 UAE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)
TABLE 222 UAE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)
TABLE 223 UAE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)
TABLE 224 uae PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)
TABLE 225 UAE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)
Lista de figuras
FIGURE 1 Global PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION
FIGURE 3 global Psychedelic drugs Market: DROC ANALYSIS
FIGURE 4 Global Psychedelic drugs market: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 Global Psychedelic drugs Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL Psychedelic drugs MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL Psychedelic drugs MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL psychedelic drugs Market: MARKET APPLICATION COVERAGE GRID
FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Global Psychedelic drugs market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Psychedelic drugs market GROWing WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS are DRIVing THE global Psychedelic drugs MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 SYNTHETIC SEGMENT is expected to account for the largest share of the global PSYCHEDELIC DRUGS MARKET in 2021 & 2028
FIGURE 15 North america is the fastest growing market FOR Psychedelic drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PSYCHEDELIC DRUGS MARKET
FIGURE 17 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP
FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP
FIGURE 19 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY GENDER
FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE, IN WORLD, IN 2017
FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.
FIGURE 22 global psychedelic drugs market: BY source, 2020
FIGURE 23 global psychedelic drugs market: BY source, 2021-2028 (USD Million)
FIGURE 24 global psychedelic drugs market: BY source, CAGR (2021-2028)
FIGURE 25 global psychedelic drugs market: BY source, LIFELINE CURVE
FIGURE 26 global psychedelic drugs market: BY type, 2020
FIGURE 27 global psychedelic drugs market: BY type, 2021-2028 (USD Million)
FIGURE 28 global psychedelic drugs market: BY type, CAGR (2021-2028)
FIGURE 29 global psychedelic drugs market: BY type, LIFELINE CURVE
FIGURE 30 global psychedelic drugs market: BY drugs, 2020
FIGURE 31 global psychedelic drugs market: BY drugs, 2021-2028 (USD Million)
FIGURE 32 global psychedelic drugs market: BY drugs, CAGR (2021-2028)
FIGURE 33 global psychedelic drugs market: BY drugs, LIFELINE CURVE
FIGURE 34 global psychedelic drugs market: BY application, 2020
FIGURE 35 global psychedelic drugs market: BY application, 2021-2028 (USD Million)
FIGURE 36 global psychedelic drugs market: BY applicaiton, CAGR (2021-2028)
FIGURE 37 global psychedelic drugs market: BY application, LIFELINE CURVE
FIGURE 38 global psychedelic drug market: BY route of administraiton, 2020
FIGURE 39 global psychedelic drug market: BY route of administration, 2020-2028 (USD Million)
FIGURE 40 global psychedelic drug market: BY route of administration, CAGR (2020-2028)
FIGURE 41 global psychedelic drug market: BY route of administration, LIFELINE CURVE
FIGURE 42 global psychedelic drug market: BY end user, 2020
FIGURE 43 global psychedelic drug market: BY end user, 2020-2028 (USD Million)
FIGURE 44 global psychedelic drug market: BY end user, CAGR (2020-2028)
FIGURE 45 global psychedelic drug market: BY end user, LIFELINE CURVE
FIGURE 46 global psychedelic drugs market: BY distribution channel, 2020
FIGURE 47 global psychedelic drugs market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 48 global psychedelic drugs market: BY distribution channel, CAGR (2020-2028)
FIGURE 49 global psychedelic drugs market: BY distribution channel, LIFELINE CURVE
FIGURE 50 GLOBAL Psychedelic Drugs MARKET: SNAPSHOT (2020)
FIGURE 51 GLOBAL Psychedelic Drugs MARKET: BY Region (2020)
FIGURE 52 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)
FIGURE 53 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)
FIGURE 54 GLOBAL Psychedelic Drugs MARKET: BY type (2021-2028)
FIGURE 55 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)
FIGURE 56 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)
FIGURE 57 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 58 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 59 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)
FIGURE 60 EUROPE PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)
FIGURE 61 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)
FIGURE 62 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 63 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 64 EUROPE PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)
FIGURE 65 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)
FIGURE 66 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)
FIGURE 67 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 68 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 69 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)
FIGURE 70 Global Psychedelic drugs market: company share 2020 (%)
FIGURE 71 north america Psychedelic drugs market: company share 2020 (%)
FIGURE 72 europe Psychedelic drugs market: company share 2020 (%)
FIGURE 73 Middle East AND Africa Psychedelic drugs market: company share 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
